Application of mesoporous silica nanoparticles in cancer therapy and delivery of repurposed anthelmintics for cancer therapy
This review focuses on the biomedical application of mesoporous silica nanoparticles
(MSNs), mainly focusing on the therapeutic application of MSNs for cancer treatment and …
(MSNs), mainly focusing on the therapeutic application of MSNs for cancer treatment and …
Mesoporous silica nanoparticles: Synthesis methods and their therapeutic use-recent advances
M Ghaferi, M Koohi Moftakhari Esfahani… - Journal of Drug …, 2021 - Taylor & Francis
Mesoporous silica nanoparticles (MSNPs) are a particular example of innovative
nanomaterials for the development of drug delivery systems. MSNPs have recently received …
nanomaterials for the development of drug delivery systems. MSNPs have recently received …
SiRNA conjugated nanoparticles—a next generation strategy to treat lung cancer
R Itani, A Al Faraj - International journal of molecular sciences, 2019 - mdpi.com
Despite major progress in both therapeutic and diagnostic techniques, lung cancer is still
considered the leading cause of cancer mortality in the world due to the ineffectiveness of …
considered the leading cause of cancer mortality in the world due to the ineffectiveness of …
Nanomedicine for glioblastoma: Progress and future prospects
Glioblastoma is the most aggressive form of brain tumor, accounting for the highest mortality
and morbidity rates. Current treatment for patients with glioblastoma includes maximal safe …
and morbidity rates. Current treatment for patients with glioblastoma includes maximal safe …
Preparation, characterization, and evaluation of cisplatin-loaded polybutylcyanoacrylate nanoparticles with improved in vitro and in vivo anticancer activities
This study aimed to evaluate the therapeutic efficacy of the cisplatin encapsulated into
polybutylcyanoacrylate (PBCA) nanoparticles for the treatment of kidney cancer. The …
polybutylcyanoacrylate (PBCA) nanoparticles for the treatment of kidney cancer. The …
In vivo glioblastoma therapy using targeted liposomal cisplatin
MS Ashrafzadeh, A Akbarzadeh… - International journal …, 2020 - Taylor & Francis
Background: Drug delivery systems have demonstrated promising results to cross blood–
brain barrier (BBB) and deliver the loaded therapeutics to the brain tumor. This study aims to …
brain barrier (BBB) and deliver the loaded therapeutics to the brain tumor. This study aims to …
Camel milk as an alternative treatment regimen for diabetes therapy
H Hussain, FH Wattoo, MHS Wattoo… - Food science & …, 2021 - Wiley Online Library
Camel milk is a valuable source of nutrition with a wide range of therapeutic effects. Its
unique composition helps to regulate the blood glucose level. The current study is aimed to …
unique composition helps to regulate the blood glucose level. The current study is aimed to …
Hypoxia‐Responsive Nanoscale Coordination Polymer Enhances the Crosstalk Between Ferroptosis and Immunotherapy
C Cai, J Zhu, X Huang, C Xu, Z Wang… - Advanced Functional …, 2023 - Wiley Online Library
The immunosuppressive tumor microenvironment (TME) severely limits the clinical
applications of cancer immunotherapy. Herein, a hypoxia‐responsive delivery system is …
applications of cancer immunotherapy. Herein, a hypoxia‐responsive delivery system is …
Enhanced efficacy of PEGylated liposomal cisplatin: In vitro and in vivo evaluation
M Ghaferi, MJ Asadollahzadeh, A Akbarzadeh… - International journal of …, 2020 - mdpi.com
This study aims to evaluate the potency of cisplatin (Cispt)-loaded liposome (LCispt) and
PEGylated liposome (PLCispt) as therapeutic nanoformulations in the treatment of bladder …
PEGylated liposome (PLCispt) as therapeutic nanoformulations in the treatment of bladder …
PEGylated Mesoporous Silica Nanoparticles (MCM-41): A promising carrier for the targeted delivery of fenbendazole into prostrate cancer cells
Low water solubility and thus low bioavailability limit the clinical application of fenbendazole
(FBZ) as a potential anticancer drug. Solubilizing agents, such as Mobil Composition of …
(FBZ) as a potential anticancer drug. Solubilizing agents, such as Mobil Composition of …